Vivos Therapeutics, Inc., a pioneering company in the field of sleep-disordered breathing, is headquartered in the United States. Founded in 2016, Vivos has rapidly established itself as a leader in the dental and medical industries, focusing on innovative solutions for obstructive sleep apnoea (OSA) and related conditions. The company’s flagship product, the Vivos System, offers a unique, non-invasive approach to treating OSA by addressing the underlying anatomical issues rather than merely alleviating symptoms. This distinctive methodology sets Vivos apart in a competitive market, contributing to its growing reputation and market position. With a commitment to improving patient outcomes, Vivos Therapeutics continues to expand its operational reach, making significant strides in the realm of sleep health.
How does Vivos Therapeutics, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Vivos Therapeutics, Inc.'s score of 23 is lower than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Vivos Therapeutics, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of emissions data and formal commitments suggests that Vivos Therapeutics may not yet have established a comprehensive framework for addressing its carbon footprint or climate impact. In the context of the industry, many companies are increasingly adopting science-based targets and sustainability initiatives to mitigate climate change. However, without specific commitments or data, Vivos Therapeutics remains outside this trend. As the company progresses, it may consider aligning with industry standards and setting measurable targets to enhance its environmental responsibility.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Vivos Therapeutics, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.